Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gilteritinib-induced severe immune-related enteritis: a possible case report.

Anti-cancer drugs - 1 Aug 2023

Luo Pan, Qiu Huiying, Yang Yushan, Wu Jiaqi, Song Xianmin, Fan Guorong, Liu Gaolin, Gao Junwei

Abstract excerpt

Gilteritinib is currently approved in China for relapsed/refractory FLT3-mutated acute myeloid leukemia, and it is very important to monitor and report its adverse drug reaction (ADR) after post-marketing. This case report describes a patient who was diagnosed with acute myeloid leukemia harboring FLT3 mutations and developed a severe suspected immune-related enteritis during treatment with gilteritinib for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aniline Compounds
Share to Leukemia, Myeloid, Acute
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pyrazines

Source

Identifiers

PMID: 37139936
DOI: 10.1097/CAD.0000000000001470

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Gilteritinib-induced severe immune-related enteritis: a possible case report.PMID 37139936Read ↗

Gilteritinib-induced severe immune-related enteritis: a possible case reportSemantic proximity Read ↗

Interim results from a postmarketing surveillance study of patients with FLT3-mutated relapsed/refractory AML treated with the FLT3 inhibitor gilteritinib in Japan.Semantic proximity Read ↗

A Case of Severe Sprue-like Enteropathy Associated With LosartanSemantic proximity Read ↗

Gilteritinib and the risk of intracranial hemorrhage: a case series of a possible, under-reported side effect.Semantic proximity Read ↗

Title: Risk factors for non-infectious diarrhea of patients with multiple myeloma after chimeric antigen receptor T-cell immunotherapy: A retrospective observational studySemantic proximity Read ↗

Risk factors for non-infectious diarrhea of patients with multiple myeloma after chimeric antigen receptor T- cell immunotherapy: A retrospective observational studySemantic proximity Read ↗

Is immune effector cell-associated enterocolitis a CAR T-cell lymphoproliferative disorder?Semantic proximity Read ↗

Nilotinib-induced liver injury: A case report.Semantic proximity Read ↗

Dermatological toxicity associated with the use of gilteritinib in relapsed acute myeloid leukemia with FLT3 mutation: a case report.Semantic proximity Read ↗

Mechanisms of lower gastrointestinal toxicity caused by tyrosine kinase inhibitorsSemantic proximity Read ↗

Gilteritinib versus chemotherapy in Japanese patients with FLT3-mutated relapsed/refractory acute myeloid leukemia.Semantic proximity Read ↗

Maintenance Treatment With Gilteritinib Suppresses Post-transplant Relapse in Relapse/Refractory FLT3-Mutated Acute Myeloid Leukemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.